Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Nemus Bioscience
Nemus Bioscience
Activities:
Ingredients
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Ingredients
Nemus and Pharmaceuticals International look to THC
Companies have agreed to develop a sterile eye drop dosage formulation, based on a cannabinoid, for Glaucoma
Drug Delivery
Suppository formulation of THC prodrug in development
The new human dosage formulation development will be used to manage chemotherapy-induced nausea
You need to be a subscriber to read this article.
Click here
to find out more.
Research & Development
High hopes for cannabis
Cannabis has a long history of therapeutic as well as recreational use. Dr Sarah Houlton considers the properties that are making it increasingly attractive to pharma companies now that its legalisation is accelerating
Subscribe now